ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Gene-editing alternative corrects Duchenne muscular dystrophy – Science Daily

Continue reading

2017-04-14 Michael Zand NEWS

Stem Cells for Knees: Promising Treatment or Hoax? – WebMD

Stem Cells for Knees: Promising Treatment or Hoax?WebMDTreatments with stem cells — which can grow into different types of cells — are booming in the U.S., with an estimated 500 or more clinics in operation. Some clinics offer treatment for condition… Continue reading

2017-04-14 Michael Zand NEWS

Immunotherapy for glioblastoma well tolerated; survival gains observed – Science Daily


Science Daily

Gene-editing alternative corrects Duchenne muscular dystrophy
Science Daily
“By either skipping a mutation region or precisely repairing a mutation in the gene, CRISPR–Cpf1-mediated genome editing not only corrects Duchenne muscular dystrophy mutations but also improves muscle contractility and strength,” said co-author Dr.

and more »

Continue reading

2017-04-14 Michael Zand NEWS

Immunotherapy for glioblastoma well tolerated; survival gains observed – Science Daily


Science Daily

Immunotherapy for glioblastoma well tolerated; survival gains observed
Science Daily
“This is a small study, but it’s one in a sequence of clinical trials we have conducted to explore the use of an immunotherapy that specifically targets a protein on glioblastoma tumors,” said Duke’s Kristen Batich, M.D., Ph.D., lead author of a study …
News Brain Cancer Vaccine–Chemotherapy Combo …Genetic Engineering & Biotechnology News
Vaccine Targeting Brain Tumors Seems Safe in StudyWebMD

all 7 news articles »

Continue reading

2017-04-14 Michael Zand NEWS

CAR-T Cell Therapy Means A Lot More Than One Or Two New Drug Approvals – Seeking Alpha


Science Daily

Immunotherapy for glioblastoma well tolerated; survival gains observed
Science Daily
“This is a small study, but it’s one in a sequence of clinical trials we have conducted to explore the use of an immunotherapy that specifically targets a protein on glioblastoma tumors,” said Duke’s Kristen Batich, M.D., Ph.D., lead author of a study …

and more »

Continue reading

2017-04-14 Michael Zand NEWS

Catching Up With US Stem Cell Inc (OTCMKTS:USRM) Ahead Of A Rebalance – Insider Financial


Seeking Alpha

CAR–T Cell Therapy Means A Lot More Than One Or Two New Drug Approvals
Seeking Alpha
The answer is that CAR–T cells present a few extra advantages to ramp up the immune response: the CAR itself – The name of the technique gives this away. “Chimeric” isn’t just a cool word (which it certainly is); it signifies that we’ve done something …

Continue reading

2017-04-14 Michael Zand NEWS

The End of Genetic Diseases – The Bulletin

The BulletinThe End of Genetic DiseasesThe BulletinDesigning humans may sound like the stuff of science fiction, but the technology that enables selective genetic modification to become a reality is here. CRISPR Cas9 is a genetic engineering technique … Continue reading

2017-04-14 Michael Zand NEWS

Immunotherapy May Increase Cancer Growth Among Certain Patients – Specialty Pharmacy Times

Immunotherapy May Increase Cancer Growth Among Certain PatientsSpecialty Pharmacy TimesImmunotherapy has become a popular and promising treatment in the oncology world, with many patients receiving the drugs instead of chemotherapy. Since these drugs w… Continue reading

2017-04-14 Michael Zand NEWS
  • 1
  • …
  • 1,844
  • 1,845
  • 1,846
  • 1,847
  • 1,848
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Insider Financial

Catching Up With US Stem Cell Inc (OTCMKTS:USRM) Ahead Of A Rebalance
Insider Financial
When we first looked at US Stem Cell Inc (OTCMKTS:USRM), we urged our readers to look beyond the metrics, and to try and form a bias based on what the company was trying to achieve, and in what space. At the time (beginning of March this year), the …
Theraputic Stem Cell-Sheet Transplantation May Improve Cardiomyopathy SymptomsThe Cardiology Advisor (registration)
How Medical Research Is Boosting Connecticut’s EconomyYale News
US Stem Cell Inc (OTCMKTS:USRM) Gets Investment Up To $5M from (GACP)The Oracle Dispatch
Medgadget (blog) –Yahoo Finance –MilTech
all 23 news articles »